A Georgia jury found pharmaceutical and agricultural products giant Bayer liable for more than $2 billion in damages.

Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product liability litigation, according to a financial analyst and a person ...

Bayer faces a $2.1 billion jury verdict in Georgia over claims that its Roundup weed killer caused a plaintiff's ...

While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the company’s pharma division was able to eke out modest sales gains of ...

Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's ...

With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its blockbuster ...

Shares of pharma conglomerate Bayer BAYRY were down 7.1% on March 24, following a setback in the ongoing Roundup Litigation. Bayer reported that, on March 21, the jury at the Barnes Roundup trial ...

Bayer's venerable testosterone replacement product for men with hypogonadism – Nebido – is being sold to Grünenthal as the group continues a revamp of its healthcare business. Grünenthal is ...

German drugmaker Bayer (BAYN: DE) has signed a global licensing agreement with China-based Puhe BioPharma, gaining exclusive ...

The National Pharmaceutical Pricing Authority (NPPA) has directed Bayer Zydus Pharma, a joint venture between Bayer and Zydus Lifesciences, to continue production and sales of various strengths and ...